[1]
S. R. Dhongdi and R. A. Siddiqui, “Polypharmacy and cost analysis in patients suffering from type 2 diabetes mellitus with associated comorbidities”, Int J Basic Clin Pharmacol, vol. 9, no. 6, pp. 929–933, May 2020.